Follow-The-Filings

Security · featured owners

SLS Sellas Life Sciences Group I

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 exit

SLS (Sellas Life Sciences Group I) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 40,000 $169K History

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 2.02,8.01,9.01
8-K 5.02,9.01
8-K 5.07
8-K 8.01,9.01
10-Q
8-K 2.02,9.01
DEFA14A
10-K
8-K 2.02,9.01
8-K 8.01,9.01
8-K 2.02,8.01,9.01
10-Q
8-K 2.02,9.01
8-K 1.01,8.01,9.01
424B5
8-K 1.01,9.01
8-K 1.01,3.02,8.01,9.01
10-Q
8-K 2.02,9.01
8-K 5.07
DEFA14A
8-K 4.01,9.01
8-K 2.02,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Jun 16, 2026
4 Period Jan 7, 2026 · 7 forms
4 Period Dec 3, 2025 · 3 forms
4 Period Nov 19, 2025
4 Period Jun 12, 2025
4 Period May 30, 2025
4 Period May 22, 2025

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.00 — —
Net income -$37.34M -$30.88M -$26.86M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.17M $16.33M $75.21M
Total non-current assets * $3.05M $3.1M $3.13M
Total assets $6.22M $19.43M $78.34M
Total current liabilities $13.74M $9.51M $7.02M
Total non-current liabilities * $460,000 $457,000 $457,000
Total equity -$7.98M $9.46M $70.87M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$31.41M -$35.4M -$28.39M
Cash from investing -$5.5M $0M —
Cash from financing $22.32M $46.76M $86.3M
Net change in cash -$14.6M $11.36M $57.91M

Ownership over time

filing count by report period · click a bar for that quarter’s holders

Period archive